Literature DB >> 33355532

Re-expression of SMARCA4/BRG1 in small cell carcinoma of ovary, hypercalcemic type (SCCOHT) promotes an epithelial-like gene signature through an AP-1-dependent mechanism.

Krystal Ann Orlando1,2, Amber K Douglas2, Aierken Abudu3, Yemin Wang4, Basile Tessier-Cloutier4,5, Weiping Su6, Alec Peters6, Larry S Sherman6,7, Rayvon Moore2, Vinh Nguyen2,8, Gian Luca Negri9, Shane Colborne9, Gregg B Morin9,10, Friedrich Kommoss11, Jessica D Lang12, William Pd Hendricks12, Elizabeth A Raupach12, Patrick Pirrotte13, David G Huntsman4,14, Jeffrey M Trent12, Joel S Parker2,15, Jesse R Raab2,15, Bernard E Weissman1,2.   

Abstract

Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is a rare and aggressive form of ovarian cancer. SCCOHT tumors have inactivating mutations in SMARCA4 (BRG1), one of the two mutually exclusive ATPases of the SWI/SNF chromatin remodeling complex. To address the role that BRG1 loss plays in SCCOHT tumorigenesis, we performed integrative multi-omic analyses in SCCOHT cell lines +/- BRG1 reexpression. BRG1 reexpression induced a gene and protein signature similar to an epithelial cell and gained chromatin accessibility sites correlated with other epithelial originating TCGA tumors. Gained chromatin accessibility and BRG1 recruited sites were strongly enriched for transcription-factor-binding motifs of AP-1 family members. Furthermore, AP-1 motifs were enriched at the promoters of highly upregulated epithelial genes. Using a dominant-negative AP-1 cell line, we found that both AP-1 DNA-binding activity and BRG1 reexpression are necessary for the gene and protein expression of epithelial genes. Our study demonstrates that BRG1 reexpression drives an epithelial-like gene and protein signature in SCCOHT cells that depends upon by AP-1 activity.
© 2020, Orlando et al.

Entities:  

Keywords:  AP-1; BRG1; Epithelial; SCCOHT; SWI/SNF; cancer biology; human; multi-omics

Mesh:

Substances:

Year:  2020        PMID: 33355532      PMCID: PMC7813545          DOI: 10.7554/eLife.59073

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  78 in total

1.  Using Peptide-Level Proteomics Data for Detecting Differentially Expressed Proteins.

Authors:  Tomi Suomi; Garry L Corthals; Olli S Nevalainen; Laura L Elo
Journal:  J Proteome Res       Date:  2015-09-29       Impact factor: 4.466

2.  Recurrent SMARCA4 mutations in small cell carcinoma of the ovary.

Authors:  Petar Jelinic; Jennifer J Mueller; Narciso Olvera; Fanny Dao; Sasinya N Scott; Ronak Shah; JianJiong Gao; Nikolaus Schultz; Mithat Gonen; Robert A Soslow; Michael F Berger; Douglas A Levine
Journal:  Nat Genet       Date:  2014-03-23       Impact factor: 38.330

3.  Loss of SMARCA4 (BRG1) protein expression as determined by immunohistochemistry in small-cell carcinoma of the ovary, hypercalcaemic type distinguishes these tumours from their mimics.

Authors:  Blaise A Clarke; Leora Witkowski; Tuyet N Ton Nu; Patricia A Shaw; C Blake Gilks; David Huntsman; Anthony N Karnezis; Neil Sebire; Janez Lamovec; Lawrence M Roth; Colin J R Stewart; Martin Hasselblatt; William D Foulkes; W Glenn McCluggage
Journal:  Histopathology       Date:  2016-07-28       Impact factor: 5.087

4.  BRG1/SMARCA4 inactivation promotes non-small cell lung cancer aggressiveness by altering chromatin organization.

Authors:  Tess Orvis; Austin Hepperla; Vonn Walter; Ian J Davis; Bernard Weissman; Shujie Song; Jeremy Simon; Joel Parker; Matthew D Wilkerson; Nisarg Desai; Michael B Major; D Neil Hayes
Journal:  Cancer Res       Date:  2014-08-12       Impact factor: 12.701

5.  Useful immunohistochemical markers of tumor differentiation.

Authors:  J T Painter; N P Clayton; R A Herbert
Journal:  Toxicol Pathol       Date:  2009-12-22       Impact factor: 1.902

6.  Heterozygous Mutations in SMARCA2 Reprogram the Enhancer Landscape by Global Retargeting of SMARCA4.

Authors:  Fangjian Gao; Nicholas J Elliott; Josephine Ho; Alexzander Sharp; Maxim N Shokhirev; Diana C Hargreaves
Journal:  Mol Cell       Date:  2019-07-30       Impact factor: 17.970

7.  Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth.

Authors:  Francesca Zanconato; Mattia Forcato; Giusy Battilana; Luca Azzolin; Erika Quaranta; Beatrice Bodega; Antonio Rosato; Silvio Bicciato; Michelangelo Cordenonsi; Stefano Piccolo
Journal:  Nat Cell Biol       Date:  2015-08-10       Impact factor: 28.824

8.  Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type.

Authors:  Anthony N Karnezis; Yemin Wang; Pilar Ramos; William Pd Hendricks; Esther Oliva; Emanuela D'Angelo; Jaime Prat; Marisa R Nucci; Torsten O Nielsen; Christine Chow; Samuel Leung; Friedrich Kommoss; Stefan Kommoss; Annacarolina Silva; Brigitte M Ronnett; Joseph T Rabban; David D Bowtell; Bernard E Weissman; Jeffrey M Trent; C Blake Gilks; David G Huntsman
Journal:  J Pathol       Date:  2015-12-21       Impact factor: 7.996

9.  An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites.

Authors:  Peter J Skene; Steven Henikoff
Journal:  Elife       Date:  2017-01-16       Impact factor: 8.140

10.  A non-canonical SWI/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation.

Authors:  Brittany C Michel; Andrew R D'Avino; Seth H Cassel; Nazar Mashtalir; Zachary M McKenzie; Matthew J McBride; Alfredo M Valencia; Qianhe Zhou; Michael Bocker; Luis M M Soares; Joshua Pan; David I Remillard; Caleb A Lareau; Hayley J Zullow; Nora Fortoul; Nathanael S Gray; James E Bradner; Ho Man Chan; Cigall Kadoch
Journal:  Nat Cell Biol       Date:  2018-11-05       Impact factor: 28.824

View more
  4 in total

1.  The SWI/SNF ATPase BRG1 facilitates multiple pro-tumorigenic gene expression programs in SMARCB1-deficient cancer cells.

Authors:  Kylie C Moe; Jack N Maxwell; Jing Wang; Cheyenne A Jones; Grace T Csaki; Andrea C Florian; Alexander S Romer; Daniel L Bryant; Anthony L Farone; Qi Liu; William P Tansey; April M Weissmiller
Journal:  Oncogenesis       Date:  2022-06-01       Impact factor: 6.524

2.  Re-expression of SMARCA4/BRG1 in small cell carcinoma of ovary, hypercalcemic type (SCCOHT) promotes an epithelial-like gene signature through an AP-1-dependent mechanism.

Authors:  Krystal Ann Orlando; Amber K Douglas; Aierken Abudu; Yemin Wang; Basile Tessier-Cloutier; Weiping Su; Alec Peters; Larry S Sherman; Rayvon Moore; Vinh Nguyen; Gian Luca Negri; Shane Colborne; Gregg B Morin; Friedrich Kommoss; Jessica D Lang; William Pd Hendricks; Elizabeth A Raupach; Patrick Pirrotte; David G Huntsman; Jeffrey M Trent; Joel S Parker; Jesse R Raab; Bernard E Weissman
Journal:  Elife       Date:  2020-12-23       Impact factor: 8.140

3.  Genomic evidence suggests that cutaneous neuroendocrine carcinomas can arise from squamous dysplastic precursors.

Authors:  Paul W Harms; Monique E Verhaegen; Kevin Hu; Steven M Hrycaj; May P Chan; Chia-Jen Liu; Marina Grachtchouk; Rajiv M Patel; Aaron M Udager; Andrzej A Dlugosz
Journal:  Mod Pathol       Date:  2021-09-30       Impact factor: 7.842

Review 4.  Emerging Themes in Mechanisms of Tumorigenesis by SWI/SNF Subunit Mutation.

Authors:  Cheyenne A Jones; William P Tansey; April M Weissmiller
Journal:  Epigenet Insights       Date:  2022-07-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.